vs

Side-by-side financial comparison of Ovid Therapeutics Inc. (OVID) and Reborn Coffee, Inc. (REBN). Click either name above to swap in a different company.

Reborn Coffee, Inc. is the larger business by last-quarter revenue ($1.4M vs $718.0K, roughly 1.9× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs 7.8%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs 0.1%).

Reborn Coffee, Inc. is a specialty coffee roaster and retailer that offers premium single-origin and blended roasted coffee beans, handcrafted espresso drinks, baked snacks and related merchandise. It operates brick-and-mortar cafe locations primarily across the United States, alongside direct-to-consumer online sales and wholesale distribution to foodservice partners, with a core focus on ethically sourced, high-quality coffee products.

OVID vs REBN — Head-to-Head

Bigger by revenue
REBN
REBN
1.9× larger
REBN
$1.4M
$718.0K
OVID
Growing faster (revenue YoY)
OVID
OVID
+837.0% gap
OVID
844.7%
7.8%
REBN
Faster 2-yr revenue CAGR
OVID
OVID
Annualised
OVID
120.3%
0.1%
REBN

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
OVID
OVID
REBN
REBN
Revenue
$718.0K
$1.4M
Net Profit
$-3.4M
Gross Margin
Operating Margin
-224.7%
Net Margin
-254.3%
Revenue YoY
844.7%
7.8%
Net Profit YoY
204.4%
-379.3%
EPS (diluted)
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OVID
OVID
REBN
REBN
Q4 25
$718.0K
Q3 25
$132.0K
$1.4M
Q2 25
$6.3M
$1.8M
Q1 25
$130.0K
$1.7M
Q4 24
$76.0K
$1.8M
Q3 24
$173.0K
$1.3M
Q2 24
$169.0K
$1.4M
Q1 24
$148.0K
$1.5M
Net Profit
OVID
OVID
REBN
REBN
Q4 25
Q3 25
$-12.2M
$-3.4M
Q2 25
$-4.7M
$-5.3M
Q1 25
$-10.2M
$-2.2M
Q4 24
$-1.8M
Q3 24
$-14.0M
$-719.7K
Q2 24
$8.5M
$-1.3M
Q1 24
$-11.7M
$-990.5K
Gross Margin
OVID
OVID
REBN
REBN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
98.7%
Operating Margin
OVID
OVID
REBN
REBN
Q4 25
Q3 25
-9487.1%
-224.7%
Q2 25
-80.9%
-240.2%
Q1 25
-9653.8%
-100.2%
Q4 24
-95.2%
Q3 24
-7645.1%
-57.6%
Q2 24
-12140.2%
-97.4%
Q1 24
-11768.2%
-56.9%
Net Margin
OVID
OVID
REBN
REBN
Q4 25
Q3 25
-9210.6%
-254.3%
Q2 25
-74.7%
-291.0%
Q1 25
-7873.1%
-129.4%
Q4 24
-100.0%
Q3 24
-8096.0%
-57.2%
Q2 24
5042.0%
-95.9%
Q1 24
-7901.4%
-65.3%
EPS (diluted)
OVID
OVID
REBN
REBN
Q4 25
Q3 25
$-0.68
Q2 25
$-1.15
Q1 25
$-0.47
Q4 24
$-0.28
Q3 24
$-0.20
$-0.30
Q2 24
$0.12
$-0.48
Q1 24
$-0.17
$-0.60

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OVID
OVID
REBN
REBN
Cash + ST InvestmentsLiquidity on hand
$13.2M
$44.0K
Total DebtLower is stronger
$500.0K
Stockholders' EquityBook value
$130.7M
$-3.4M
Total Assets
$150.9M
$6.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OVID
OVID
REBN
REBN
Q4 25
$13.2M
Q3 25
$20.6M
$44.0K
Q2 25
$28.4M
$77.9K
Q1 25
$21.1M
$777.1K
Q4 24
$26.3M
$158.2K
Q3 24
$15.0M
$105.9K
Q2 24
$29.7M
$617.1K
Q1 24
$30.8M
$70.3K
Total Debt
OVID
OVID
REBN
REBN
Q4 25
Q3 25
$500.0K
Q2 25
$500.0K
Q1 25
$500.0K
Q4 24
$500.0K
Q3 24
$500.0K
Q2 24
$500.0K
Q1 24
$500.0K
Stockholders' Equity
OVID
OVID
REBN
REBN
Q4 25
$130.7M
Q3 25
$44.7M
$-3.4M
Q2 25
$55.8M
$-1.9M
Q1 25
$59.3M
$415.6K
Q4 24
$68.2M
$2.6M
Q3 24
$76.3M
$2.7M
Q2 24
$88.9M
$2.5M
Q1 24
$78.3M
$2.6M
Total Assets
OVID
OVID
REBN
REBN
Q4 25
$150.9M
Q3 25
$63.8M
$6.2M
Q2 25
$77.4M
$6.4M
Q1 25
$81.7M
$8.1M
Q4 24
$92.2M
$7.8M
Q3 24
$102.7M
$9.6M
Q2 24
$118.1M
$10.5M
Q1 24
$131.6M
$10.9M
Debt / Equity
OVID
OVID
REBN
REBN
Q4 25
Q3 25
Q2 25
Q1 25
1.20×
Q4 24
0.19×
Q3 24
0.19×
Q2 24
0.20×
Q1 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OVID
OVID
REBN
REBN
Operating Cash FlowLast quarter
$-38.3M
$-1.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OVID
OVID
REBN
REBN
Q4 25
$-38.3M
Q3 25
$-12.9M
$-1.6M
Q2 25
$-4.8M
$-3.6M
Q1 25
$-10.3M
$464.6K
Q4 24
$-56.0M
$-132.6K
Q3 24
$-15.0M
$-424.0K
Q2 24
$-14.3M
$-961.8K
Q1 24
$-16.7M
$-1.9M
Free Cash Flow
OVID
OVID
REBN
REBN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-56.0M
$-600.9K
Q3 24
$-15.0M
$-424.0K
Q2 24
$-14.3M
$-1.3M
Q1 24
$-16.7M
$-2.9M
FCF Margin
OVID
OVID
REBN
REBN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-73719.7%
-33.8%
Q3 24
-8676.9%
-33.7%
Q2 24
-8455.0%
-95.3%
Q1 24
-11287.2%
-192.4%
Capex Intensity
OVID
OVID
REBN
REBN
Q4 25
0.0%
Q3 25
0.0%
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
93.4%
26.3%
Q3 24
2.3%
0.0%
Q2 24
20.1%
25.2%
Q1 24
12.8%
65.0%
Cash Conversion
OVID
OVID
REBN
REBN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.67×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OVID
OVID

Segment breakdown not available.

REBN
REBN

Stores$1.1M83%
Other$229.9K17%

Related Comparisons